Abstract
Prostatic artery embolization (PAE) is a safe and effective alternative for managing lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and can be used readily in larger prostates. This study was undertaken to compare the long-term clinical outcomes of PAE in patients with >100ml vs < 100ml PV.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
